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Background: There is growing evidence that Cognitive Simulation Therapy (CST) benefits cognition and quality of
life of people with dementia, but little is known about the indirect effects of this intervention on family caregivers.
This study sought to investigate the effect of CST on family caregivers general health status of people with
dementia living in the community attending the CST intervention.
Method: Eighty-five family caregivers of people with dementia took part in the study. All the people with dementia
received the standard twice weekly seven weeks of the CST intervention plus either 24 weeks of a maintenance
CST (MCST) intervention or 24 weeks of treatment as usual. Family caregivers were assessed before and after their
relatives the CST programme, and after 3 and 6 months of the MCST programme. A pre and post CST groups
comparison was undertaken to evaluate the open trial first phase and an ANCOVA model used to analyse the
maintenance phase with its controlled comparison.
Results: We found no evidence for a benefit on the family caregiver outcome measures of the intervention before
and after CST groups by using a t-test analysis or any significant differences between intervention and control
groups for any of the variables considered at any time point (3 and 6 month follow up).
Conclusion: CST seems to have a relatively specific benefit fpr people with dementia that may not carry over to
family carers. Future studies need to further explore and compare the effects that CST might bring to family
caregivers of people with dementia attending the intervention.
Trial registration: Current Controlled Trials ISRCTN26286067
Keywords: Dementia, Alzheimer’s disease, Family caregivers, Cognitive stimulation, Quality of lifeBackground
It has been estimated that currently 35.6 million people
live with dementia and this number will increase in 2050
by 115.4 million [1]. The majority of people with demen-
tia are cared for at home and looked after by a member
of the family or close friend [2] and therefore, as the
number of people with dementia increases so will the
number of family caregivers. Being a carer for people
with dementia has been associated with frequent use of
medication and increased visits to health professionals* Correspondence: e.aguirre@ucl.ac.uk
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reproduction in any medium, provided the or[3,4], as well as with poor clinical outcomes such as de-
pression, illness and decreased quality of life [5]. Demen-
tia caregiving has also been linked with poor outcomes
for people with dementia such as poor quality of life and
increased risk of nursing home placement [6,7].
Systematic reviews have found cognitive stimulation to
be a psychosocial intervention for people with dementia
[1,8-10], which has robust evidence. Cognitive stimula-
tion programmes target cognition but have a social
element usually in a group or with the family caregiver,
and the included cognitive activities do not primarily
consist of practice on specific cognitive modalities [11].
Evidence in relation to its effectiveness on family
caregiver outcome measures is less conclusive. The
Cochrane review found only three studies reporting onLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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no differences were noted and the effect sizes for anxiety,
depression and caregiver burden were close to zero, indi-
cating no likely differences in caregiver outcomes [10]. In
one study [12], the family caregivers were trained to de-
liver the intervention, without showing any adverse effect
on them [10].
Generally the effectiveness of interventions has been
judged in relation to how far the specific outcomes re-
late to the specific person targeted (person with demen-
tia or family caregiver). However, there is little evidence
as to whether interventions targeted at people with de-
mentia might benefit carers. So far the dominant con-
ceptual model for caregiving is the stress-coping model
[15] that assumes that the onset and progression of
chronic illness and physical disability are stressful for
both the person with dementia and the family caregiver
[15]. Therefore, under this framework, it is expected that
CST by increasing the person with dementia’s cognitive
abilities and well being, may lead to an improvement in
family caregivers mood and wellbeing.
The aim of this study is to examine the impact on the




Participants were family caregivers of people with de-
mentia living in the community who were taking part in
a large randomised control trial of Maintenance CST
(MCST) for dementia [16,17]. Ethical approval was ob-
tained through the Multi-centre Research Ethics Commit-
tee (ref no. 08/H0702/68). The clinical trial is registered –





Assessed at Follow up 1
(n =34)








Figure 1 Trial flow chart.January 2009 till September 2010 in community settings
in London, Essex and Bedfordshire. Family caregivers were
referred by the manager from the day centre or commu-
nity mental health team where the CST trial groups were
taking place. Family caregivers were contacted and invited
for a meeting where the purpose of the trial was explained
and if consented were recruited with their relatives for the
study.
Design
People with dementia received standard CST which is
a seven-week 14-session group psychosocial treatment
for dementia that is effective in improving cognition
and quality of life [18]. They were then randomised
into either [a] the maintenance CST programme once
weekly for 24 weeks or [b] treatment as usual [17]
(Figure 1). Assessments of the family caregivers were
conducted in the week prior to and following their
relatives participation in the standard CST inter-
vention, and at three and six month follow up after
randomisation into the maintenance programme group or
treatment as usual.
Intervention
The intervention included the standard CST programme,
14-sessions run twice weekly [19,20] followed by the
Maintenance CST programme [21,22] or treatment as
usual. The intervention was based on the theory of
cognitive stimulation as applied to the original CST
programme [19] guided by the MRC framework [23]
for complex interventions. The complete CST and
Mainteance CST programme, incorporated the use of
an “RO board”, displaying both personal and orienta-
tion information, including the group name (as8) 
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Table 1 Sociodemographic characteristics at baseline
1 (n = 98)
Characteristics





Other (Grand-daughter, Warden) 2 (2%)
Carer living situation 55% Lives in
Type of dementia
Alzheimer’s type 45 (46%)
Vascular type 16 (16%)
Other 15 (15%)
Not known 20 (20%)
Missing 2 (2%)





Table 2 Sociodemographic characteristics at baseline 2




Spouse 19 23 42
Child (inc. niece/nephew) 21 17 38
Brother/Sister 0 2 2




Lives with 24 26 50
Doesn’t live with 17 18 35
Type of dementia Alzheimer’s type 12 25 37
Vascular type 8 4 12
Other 10 5 15
Not known 9 10 19
Missing 1 1 2
Carer Status Retired 7 19 26
Employed 12 10 22
Unemployed 4 1 5
Housewife/Househusband 0 1 1
Missing 13 15 28
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intervention involved using new ideas, thoughts and
associations; using orientation sensitively and implicitly;
a focus on opinions rather than facts; using reminis-
cence as an aid to the here-and-now; providing triggers
to aid recall; creation of continuity and consistency be-
tween sessions; focus on implicit (rather than explicit)
learning; stimulating language; stimulating executive
functioning and being person-centred (treating people
as unique individuals with their own personality and
preferences). Each group had two facilitators, one from
the research team and a co-facilitator who was a mem-
ber of staff from the recruited centre (e.g. residential
care home). The use of two facilitators for each group
enabled effective de-briefing and reflection to occur at
the end of each session.
Assessment measures
EQ-5D
EQ-5D [24] is a standardized instrument for use as a
measure of health outcome. Applicable to a wide range
of health conditions and treatments, it provides a sim-
ple descriptive profile and a single index value for
health status. EQ-5D was originally designed to comple-
ment other instruments but is now increasingly used as a
'stand alone' measure. EQ-5D is designed for self-
completion by respondents, and is easy, taking only a few
minutes to complete. Instructions for family caregivers to
follow were included in the questionnaire. The scaleincludes a 3- level (1 = no problem, 2 =moderate problem,
3 = severe problem), 5-dimensional format and the Visual
Analogue Scale [VAS] with a maximum score of 100 indi-
cating the best health status.
SF-12
The Short Form-12 UK [25] Health Survey measures
generic health concepts relevant across age, disease,
and treatment groups. It provides a comprehensive,
psychometrically sound, and efficient way to measure
health from the patient's point of view by scoring
standardized responses to standard questions. The SF-12
includes 8 concepts commonly represented in health sur-
veys: physical functioning, role functioning physical, bod-
ily pain, general health, vitality, social functioning, role
functioning emotional, and mental health.
Analysis
For the before and after CST data the analysis followed
a paired sample t-test analysis. For the maintenance CST
or treatment as usual phase, an ANCOVA model was fit-
ted for each of the follow up time points. The ANCOVA
model incorporated centre as a random factor and base-
line 2 score (post CST) as a covariate.
Results
Tables 1 and 2 presents baseline data before and after
the CST groups on sociodemographic and service use
variables. Generally participants were female (n = 84;
Table 3 Family caregiver outcomes before and after CST (Baseline 1 to Baseline 2)
Measure n for CC Before CST mean (SE) After CST mean (SE) Difference t value p value Effect size
SF-12b PCS 85 38.14 (6.39) 38.84 (6.31) 0.70 (6.01) 1.071 .29 0.12
SF-12 MCS 85 42.25 (5.25) 42.33 (5.13) 0.08 (5.62) 0.134 .89 0.01
EQ-5Db Utility 82 0.82 (.21) 0.84 (0.21) 0.02 (.205) 0.78 .44 0.08
EQ-5Db VAS 82 71.73 (16.85) 74.61 (18.26) 2.87 (16.08) 1.62 .11 0.18
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dementia (n = 44; 45%) or son/daughters (n = 47; 48%). Al-
most all were providing daily assistance to people with a
diagnosis of Alzheimer’s type of dementia (n = 45; 46%).
The mean age of the people with dementia was at 81
[range 52–97] years. Overall retention was good. We
followed up 71 (83.5%) participants at 3 months and 63
(74.1%) at six months.
Table 3 shows the analysis of the first phase of the study.
There was no evidence for a benefit of intervention imme-
diately after the standard CST group programme on the
family caregiver outcome measures. Table 4 shows the
analyses of the ANCOVA for the Maintenance stage of
the programme. Again, we found no evidence of any sig-
nificant differences between groups for any of the variables
considered at any time point. [3 and 6 month follow up].
Discussion
This study evaluated the potential indirect effects of CST
on the family caregivers general health status and quality
of life. The standard twice weekly for seven weeks CST
intervention showed benefits to cognition and quality of
life for people with dementia [18] and the maintenance
programme showed to benefit quality of life of people with
dementia at 6 months [19] and cognition for people on
cholinesterase inhibitors [19]. However, we found no
evidence for a benefit on the family caregiver outcome
measures.
The external validity of this trial is high though two
aspects limit its generalisability, lack of ethnic mix and
wide geographical spread. Participants were almost ex-
clusively white British and therefore we cannot draw
conclusions on the effectiveness of this intervention for
other ethnical backgrounds or cultures. In addition, it
may be that an effect would be found with a larger num-
bers of family carers.Table 4 Effects of Maintenance CST on adjusted complete cas
FU1- 3 month follow up
Treatment Control Difference
Adjusted outcomes n Mean (SE) Mean (SE) Mean (SE)
SF-12 PCS 71 39.07 (0.93) 39.26 (0.97) 0.19 (1.34)
SF-12 MCS 71 42.43 (0.76) 43.04 (0.80) 0.61 (1.11)
EQ-5D Utility 70 0.83 (0.02) 0.81 (0.02) −0.02(0.03)
EQ-5D VAS 70 75.86 (2.05) 74.04 (2.17) −1.82 (2.99)Research so far suggests two basic types of interventions
to help and support people caring for a relative or a friend
with dementia. These range from those [a] providing direct
practical assistance with care by the provision of respite
care, to [b] interventions directly delivered to family care-
givers by offering psycho educational or psychosocial sup-
port. Non-cognitive features of dementia are most likely
to be associated with psychological problems in caregivers
[26]. The stress/health model as the dominant theoretical
model guiding the design of caregiver interventions, as-
sumes that the severity of dementia is one of the primary
stressors on the caregiver [27]. Thus, our study hypothe-
sized that if CST can improve cognitive abilities and in-
crease their quality of life, this effect could potentially
have a beneficial effect on family caregivers. As the per-
ceived health of the family caregivers is not only related to
cognitive impairment of the person with dementia, but
also to the behavioural and psychological symptoms in de-
mentia [26], further studies should include these variables
in their analysis when evaluating further the indirect effect
of this intervention.
Different types of interventions for people with de-
mentia may be more or less effective depending upon
the nature of the relationship between the caregiver
and the care recipient. It might be that a cognitive
based intervention delivered by a family caregiver such
as individualized CST [28] might be of greater success
in positively influencing both partners. In a pilot study,
Moniz-Cook et al. [29] found that a home-based memory
management programme involving the family carer led
to improvements in memory in the person with de-
mentia, improvements in carer wellbeing, and a reduc-
tion in care home admissions at 18 months follow-up.
Similarly benefits in cognition in people with dementia
and carer wellbeing have been reported in studies by
Quayhagen et al. [30].e (CC) outcomes at primary and secondary end points
FU2- 6 month follow up
p value Treatment Control Difference p value
n Mean (SE) Mean (SE) Mean (SE)
.89 63 37.89 (0.94) 38.44 (1.02) 0.55 (1.39) .70
.58 63 41.88 (0.85) 42.91 (0.92) 1.03 (1.26) .42
.52 63 0.79 (0.02) 0.84 (0.02) 0.05 (0.03) .12
.57 63 74.41 (2.33) 72.28 (2.52) −2.14 (3.43) .54
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Group CST interventions benefit people with demen-
tia but there is little evidence to suggest that they may
be beneficial for family caregivers. Conclusions from
this study are only preliminary and therefore further
studies need to improve the methodological qualities
of this type of study, for instance, increasing sample
size and measuring a wider range of family caregivers
outcomes (eg. burden, knowledge, anxiety, depression,
quality of life). Further studies could also explore the
impact of individual CST on different family caregiver
outcomes.
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